Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV

By sjmartinez • October 22, 2024

Zanni MV, Umbleja T, Fichtenbaum CJ, Fitch KV, McCallum S, Aberg JA, Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Schnittman SR, Erlandson KM, Diggs MR, Foldyna B, Martinez E, Somboonwit C, Wang GP, Mushatt D, Connick E, Lu MT, Douglas PS, Ribaudo HJ, Grinspoon SK. Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV. Open Forum Infect Dis. 2024 Oct 10;11(10):ofae574. doi: 10.1093/ofid/ofae574. PMID: 39435321; PMCID: PMC11493083.

Tags: covid-19, HIV, Infectious Diseases, Publications, PWH, REPRIEVE, statin

Diagnostic stewardship cutoffs for urinalysis results prior to performing a urine culture: analysis of data from a healthcare system

Kupferwasser DK, Kang AY, Bolaris M, Huse H, Chen L, Miller L. Diagnostic stewardship cutoffs for urinalysis results prior to performing a urine culture: analysis[...]

Bispecific antibodies cross-link and redirect CD8+ T cells to kill cytomegalovirus-infected cells

Ali A, Balamurugan A, Ibarrondo FJ, Nguyen M, Habibipour S, Lim JM, Hofmann C, Ng HL, Yang OO. Bispecific antibodies cross-link and redirect CD8+ T cells[...]

Inflammation among kidney transplant donors with and without HIV: Multicenter HOPE in Action Consortium

Zaman F, Zhu X, Hunt JH, Rozek G, Eby Y, Hussain S, Desai NM, Florman S, Rana MM, Friedman-Moraco R, Pereira MR, Mehta S, Stock[...]